A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H<sub>2</sub>S therapy-Reference-Cited by-同舟云学术

A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H₂S therapy

Published:2023 Issue:45 Volume:11 Page:10822-10835
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Liu Mingzhe¹,Xu Hui²^ORCID,Zhou FangFang³,Gong Xiyu³,Tan Songwen⁴,He Yongju¹^ORCID

Affiliation:

1. School of Materials Science and Engineering, Central South University, Changsha, Hunan 410083, China

2. Institute of Super-Microstructure and Ultrafast Process in Advanced Materials, School of Physics and Electronics, Central South University, Changsha, Hunan 410083, China

3. Department of Neurology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China

4. Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China

Abstract

A nanoplatform with functions of the Fenton-reaction, self-supplied H2O2, GSH-elimination, H2S generation and DOX delivery for synergistic multi-enhanced CDT/chemotherapy/H2S cancer therapy.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Fundamental Research Funds for the Central Universities

Central South University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB02147E

Reference40 articles.